��������

Jonathan Houze is currently the Head of Chemistry at Vigil Neuroscience. Previously, Jonathan held the title of Director, Research at Amgen for over 15 years, where Jonathan led various programs against cardiovascular disease, pain, and neurodegenerative disease. With extensive experience in medicinal chemistry, Jonathan has been involved in the development and delivery of multiple clinical candidates, including compounds evaluated in Phase I and Phase II clinical trials. Jonathan's expertise and leadership skills have been instrumental in driving successful research collaborations and licensing deals throughout their career.